Roberts David B — SEC Form 4 filings
SEC reporting owner CIK 1365731. 33 Form 4 filings on record with FilingPulse; latest filed 2026-09-08.
Transaction summary — filings shown
Covers all 33 filings on record, filed 2024-02-15 to 2026-09-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 7 legs across 5 filings — 30,679 shares, $2,891,088 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 165.
- Largest priced transaction: sale of 8,464 shares @ $106.80 ($903,958) in LEMAITRE VASCULAR INC, filed 2026-03-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| LEMAITRE VASCULAR INC (LMAT) | President and Director, Director | 31 | — | 7 legs · 30,679 sh · $2,891,088 | 161 |
| Anteris Technologies Global Corp. (AVR) | Director | 2 | — | — | 4 |
Form 4 filings — Roberts David B
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-08 | 4 | LEMAITRE VASCULAR INC (LMAT) | Grant/award (A): 2.13 (derivative) @ $0 · Grant/award (A): 2.13 (derivative) @ $0 · Grant/award (A): 3.63 (derivative) @ $0 · Grant/award (A): 4.35 (derivative) @ $0 · Grant/award (A): 3.16 (derivative) @ $0 · Grant/award (A): 3.58 (derivative) @ $0 · +3 more | EDGAR |
| 2026-06-09 | 4 | Anteris Technologies Global Corp. (AVR) | Option exercise (M): 17,580 · Option exercise (M): 17,580 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | LEMAITRE VASCULAR INC (LMAT) | Grant/award (A): 1.82 (derivative) @ $0 · Grant/award (A): 1.82 (derivative) @ $0 · Grant/award (A): 3.12 (derivative) @ $0 · Grant/award (A): 3.73 (derivative) @ $0 · Grant/award (A): 2.71 (derivative) @ $0 · Grant/award (A): 3.07 (derivative) @ $0 · +3 more | EDGAR |
| 2026-03-30 | 4 | LEMAITRE VASCULAR INC (LMAT) | Grant/award (A): 1.54 (derivative) @ $0 · Grant/award (A): 1.54 (derivative) @ $0 · Grant/award (A): 2.64 (derivative) @ $0 · Grant/award (A): 3.16 (derivative) @ $0 · Grant/award (A): 2.29 (derivative) @ $0 · Grant/award (A): 2.60 (derivative) @ $0 · +3 more | EDGAR |
| 2026-03-13 | 4 | LEMAITRE VASCULAR INC (LMAT) | Sale (S): 3,311.68 @ $107.68 | EDGAR |
| 2026-03-02 | 4 | LEMAITRE VASCULAR INC (LMAT) | Grant/award (A): 1,514 @ $0 · Grant/award (A): 146 @ $0 · Option exercise (M): 3 @ $0 · Tax withholding (F): 134 @ $113.69 · Tax withholding (F): 13 @ $113.69 · Sale (S): 8,464 @ $106.80 · +1 more | EDGAR |
| 2026-02-06 | 4 | LEMAITRE VASCULAR INC (LMAT) | Option exercise (M): 2,672 @ $37.29 · Option exercise (M): 7 @ $48.60 · Option exercise (M): 2,672 (derivative) @ $0 · Option exercise (M): 7 (derivative) @ $0 | EDGAR |
| 2025-12-15 | 4 | LEMAITRE VASCULAR INC (LMAT) | Option exercise (M): 25 @ $0 · Tax withholding (F): 297 @ $83.36 · Option exercise (M): 18 @ $0 · Tax withholding (F): 302 @ $84 · Option exercise (M): 18 @ $0 · Tax withholding (F): 302 @ $84 · +3 more | EDGAR |
| 2025-12-11 | 4 | LEMAITRE VASCULAR INC (LMAT) | Grant/award (A): 1,694 @ $0 · Grant/award (A): 10,400 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | LEMAITRE VASCULAR INC (LMAT) | Option exercise (M): 9 @ $0 · Tax withholding (F): 230 @ $82.93 · Option exercise (M): 11 @ $0 · Tax withholding (F): 205 @ $82.93 · Option exercise (M): 9 (derivative) @ $0 · Option exercise (M): 11 (derivative) @ $0 | EDGAR |
| 2025-12-08 | 4 | LEMAITRE VASCULAR INC (LMAT) | Option exercise (M): 3 @ $0 · Tax withholding (F): 99 @ $84.53 · Tax withholding (F): 10 @ $84.53 · Grant/award (A): 1.56 (derivative) @ $0 · Grant/award (A): 3.17 (derivative) @ $0 · Grant/award (A): 3.17 (derivative) @ $0 · +5 more | EDGAR |
| 2025-12-05 | 4 | Anteris Technologies Global Corp. (AVR) | Grant/award (A): 52,742 (derivative) @ $0 · Grant/award (A): 13,821 (derivative) @ $0 | EDGAR |
| 2025-12-03 | 4 | LEMAITRE VASCULAR INC (LMAT) | Option exercise (M): 15 @ $0 · Tax withholding (F): 107 @ $83.68 · Option exercise (M): 15 (derivative) @ $0 | EDGAR |
| 2025-09-08 | 4 | LEMAITRE VASCULAR INC (LMAT) | Grant/award (A): 0.72 (derivative) @ $0 · Grant/award (A): 1.37 (derivative) @ $0 · Grant/award (A): 2.79 (derivative) @ $0 · Grant/award (A): 2.79 (derivative) @ $0 · Grant/award (A): 3.58 (derivative) @ $0 · Grant/award (A): 4.29 (derivative) @ $0 · +2 more | EDGAR |
| 2025-08-13 | 4 | LEMAITRE VASCULAR INC (LMAT) | Option exercise (M): 3,979 @ $37.29 · Option exercise (M): 123 @ $35.48 · Sale (S): 3,718 @ $92.53 · Sale (S): 384 @ $91.55 · Option exercise (M): 6,713 @ $37.29 · Sale (S): 6,713 @ $92.35 · +3 more | EDGAR |
| 2025-06-02 | 4 | LEMAITRE VASCULAR INC (LMAT) | Grant/award (A): 0.86 (derivative) @ $0 · Grant/award (A): 1.64 (derivative) @ $0 · Grant/award (A): 3.34 (derivative) @ $0 · Grant/award (A): 3.34 (derivative) @ $0 · Grant/award (A): 4.28 (derivative) @ $0 · Grant/award (A): 5.12 (derivative) @ $0 · +2 more | EDGAR |
| 2025-03-31 | 4 | LEMAITRE VASCULAR INC (LMAT) | Grant/award (A): 0.83 (derivative) @ $0 · Grant/award (A): 1.58 (derivative) @ $0 · Grant/award (A): 3.21 (derivative) @ $0 · Grant/award (A): 3.21 (derivative) @ $0 · Grant/award (A): 4.12 (derivative) @ $0 · Grant/award (A): 4.94 (derivative) @ $0 · +2 more | EDGAR |
| 2025-03-11 | 4 | LEMAITRE VASCULAR INC (LMAT) | Option exercise (M): 2,818 @ $35.48 · Option exercise (M): 2,818 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | LEMAITRE VASCULAR INC (LMAT) | Grant/award (A): 685 @ $0 · Option exercise (M): 5 @ $0 · Tax withholding (F): 203 @ $91.85 · Option exercise (M): 5 (derivative) @ $0 | EDGAR |
| 2025-02-20 | 4 | LEMAITRE VASCULAR INC (LMAT) | Grant/award (A): 129 @ $0 · Grant/award (A): 741 (derivative) @ $0 | EDGAR |
| 2024-12-26 | 4 | LEMAITRE VASCULAR INC (LMAT) | Option exercise (M): 17 @ $0 · Tax withholding (F): 115 @ $92.12 · Option exercise (M): 17 (derivative) @ $0 | EDGAR |
| 2024-12-13 | 4 | LEMAITRE VASCULAR INC (LMAT) | Option exercise (M): 18 @ $0 · Tax withholding (F): 196 @ $101 · Option exercise (M): 11 @ $0 · Option exercise (M): 11 @ $0 · Tax withholding (F): 197 @ $100.28 · Tax withholding (F): 197 @ $100.28 · +3 more | EDGAR |
| 2024-12-11 | 4 | LEMAITRE VASCULAR INC (LMAT) | Option exercise (M): 4 @ $0 · Tax withholding (F): 169 @ $101.12 · Option exercise (M): 4 (derivative) @ $0 | EDGAR |
| 2024-12-10 | 4 | LEMAITRE VASCULAR INC (LMAT) | Grant/award (A): 1,335 @ $0 · Grant/award (A): 7,662 (derivative) @ $0 | EDGAR |
| 2024-12-09 | 4 | LEMAITRE VASCULAR INC (LMAT) | Grant/award (A): 0.58 (derivative) @ $0 · Grant/award (A): 0.54 (derivative) @ $0 · Grant/award (A): 2.06 (derivative) @ $0 · Grant/award (A): 3.15 (derivative) @ $0 · Grant/award (A): 3.15 (derivative) @ $0 · Grant/award (A): 3.59 (derivative) @ $0 | EDGAR |
| 2024-12-04 | 4 | LEMAITRE VASCULAR INC (LMAT) | Option exercise (M): 12 @ $0 · Tax withholding (F): 106 @ $105.47 · Option exercise (M): 12 (derivative) @ $0 | EDGAR |
| 2024-09-03 | 4 | LEMAITRE VASCULAR INC (LMAT) | Grant/award (A): 0.66 (derivative) @ $0 · Grant/award (A): 1.25 (derivative) @ $0 · Grant/award (A): 2.38 (derivative) @ $0 · Grant/award (A): 3.64 (derivative) @ $0 · Grant/award (A): 3.64 (derivative) @ $0 · Grant/award (A): 4.15 (derivative) @ $0 | EDGAR |
| 2024-08-15 | 4 | LEMAITRE VASCULAR INC (LMAT) | Option exercise (M): 122 @ $23.56 · Option exercise (M): 2,941 @ $35.48 · Sale (S): 3,063 @ $82.07 · Option exercise (M): 122 (derivative) @ $0 · Option exercise (M): 2,941 (derivative) @ $0 | EDGAR |
| 2024-06-03 | 4 | LEMAITRE VASCULAR INC (LMAT) | Grant/award (A): 0.75 (derivative) @ $0 · Grant/award (A): 1.41 (derivative) @ $0 · Grant/award (A): 2.67 (derivative) @ $0 · Grant/award (A): 4.09 (derivative) @ $0 · Grant/award (A): 4.09 (derivative) @ $0 · Grant/award (A): 4.66 (derivative) @ $0 | EDGAR |
| 2024-05-08 | 4 | LEMAITRE VASCULAR INC (LMAT) | Sale (S): 5,025 @ $75.62 | EDGAR |
| 2024-04-01 | 4 | LEMAITRE VASCULAR INC (LMAT) | Grant/award (A): 0.88 (derivative) @ $0 · Grant/award (A): 1.66 (derivative) @ $0 · Grant/award (A): 3.17 (derivative) @ $0 · Grant/award (A): 4.84 (derivative) @ $0 · Grant/award (A): 4.84 (derivative) @ $0 · Grant/award (A): 5.51 (derivative) @ $0 | EDGAR |
| 2024-03-04 | 4 | LEMAITRE VASCULAR INC (LMAT) | Grant/award (A): 2,649 @ $0 · Option exercise (M): 6 @ $0 · Tax withholding (F): 196 @ $70 · Option exercise (M): 6.68 (derivative) @ $0 | EDGAR |
| 2024-02-15 | 4 | LEMAITRE VASCULAR INC (LMAT) | Option exercise (M): 4,244 @ $23.56 · Option exercise (M): 2 @ $0 · Option exercise (M): 4,244 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1365731 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →